Stockreport

Chiesi buys into Arbor gene editing drug for rare kidney disease [Yahoo! Finance]

Gossamer Bio, Inc.  (GOSS) 
Last gossamer bio, inc. earnings: 3/24 07:00 am Check Earnings Report
PDF Chiesi Group has formed an alliance with Arbor Biotechnologies that gives the Italian pharmaceutical company ownership of an experimental gene editing treatment for a r [Read more]